{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:58:47Z","timestamp":1751468327975},"reference-count":43,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00380","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T22:07:02Z","timestamp":1473286022000},"page":"1948-1954","source":"Crossref","is-referenced-by-count":9,"title":["The Activity of Fungichromin against the Formation of &lt;i&gt;Candida albicans&lt;\/i&gt; Biofilm"],"prefix":"10.1248","volume":"39","author":[{"given":"Duopeng","family":"An","sequence":"first","affiliation":[{"name":"Department of Biosynthetic Medicinal Chemistry, School of Pharmacy, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biosynthetic Medicinal Chemistry, School of Pharmacy, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biosynthetic Medicinal Chemistry, School of Pharmacy, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Biosynthetic Medicinal Chemistry, School of Pharmacy, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoJuan","family":"Ma","sequence":"additional","affiliation":[{"name":"Huashan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Huashan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Shi","sequence":"additional","affiliation":[{"name":"Huashan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Sun","sequence":"additional","affiliation":[{"name":"Huashan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Biosynthetic Medicinal Chemistry, School of Pharmacy, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biosynthetic Medicinal Chemistry, School of Pharmacy, Fudan University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) He M, Du M, Fan M, Bian Z. <i>In vitro<\/i> activity of eugenol against <i>Candida albicans<\/i> biofilms. <i>Mycopathologia<\/i>, <b>163<\/b>, 137\u2013143 (2007).","DOI":"10.1007\/s11046-007-0097-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) van de Veerdonk FL, Kullberg B-J, Netea MG. Pathogenesis of invasive candidiasis. <i>Curr. Opin. Crit. Care<\/i>, <b>16<\/b>, 453\u2013459 (2010).","DOI":"10.1097\/MCC.0b013e32833e046e"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lai C-C, Tan C-K, Huang Y-T, Shao P-L, Hsueh P-R. Current challenges in the management of invasive fungal infections. <i>J. Infect. Chemother.<\/i>, <b>14<\/b>, 77\u201385 (2008).","DOI":"10.1007\/s10156-007-0595-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tobudic S, Kratzer C, Lassnigg A, Presterl E. Antifungal susceptibility of <i>Candida albicans<\/i> in biofilms. <i>Mycoses<\/i>, <b>55<\/b>, 199\u2013204 (2012).","DOI":"10.1111\/j.1439-0507.2011.02076.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kojic EM, Darouiche RO. Candida infections of medical devices. <i>Clin. Microbiol. Rev.<\/i>, <b>17<\/b>, 255\u2013267 (2004).","DOI":"10.1128\/CMR.17.2.255-267.2004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ramage G, Mart\u00ednez JP, L\u00f3pez-Ribot JL. <i>Candida<\/i> biofilms on implanted biomaterials: a clinically significant problem. <i>FEMS Yeast Res.<\/i>, <b>6<\/b>, 979\u2013986 (2006).","DOI":"10.1111\/j.1567-1364.2006.00117.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. <i>Eukaryot. Cell<\/i>, <b>4<\/b>, 633\u2013638 (2005).","DOI":"10.1128\/EC.4.4.633-638.2005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, L\u00f3pez-Ribot JL. Antifungal therapy with an emphasis on biofilms. <i>Curr. Opin. Pharmacol.<\/i>, <b>13<\/b>, 726\u2013730 (2013).","DOI":"10.1016\/j.coph.2013.08.008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sanglard D, Odds FC. Resistance of <i>Candida<\/i> species to antifungal agents: molecular mechanisms and clinical consequences. <i>Lancet Infect. Dis.<\/i>, <b>2<\/b>, 73\u201385 (2002).","DOI":"10.1016\/S1473-3099(02)00181-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Brajtburg J, Elberg S, Kobayashi GS, Medoff G. Effects of serum lipoproteins on damage to erythrocytes and <i>Candida albicans<\/i> cells by polyene antibiotics. <i>J. Infect. Dis.<\/i>, <b>153<\/b>, 623\u2013626 (1986).","DOI":"10.1093\/infdis\/153.3.623"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Chen WC, Chou D-L, Feingold DS. Dissociation between ion permeability and the lethal action of polyene antibiotics on <i>Candida albicans<\/i>. <i>Antimicrob. Agents Chemother.<\/i>, <b>13<\/b>, 914\u2013917 (1978).","DOI":"10.1128\/AAC.13.6.914"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kranzler M, Syrowatka M, Leitsch D, Winnips C, Walochnik J. Pentamycin shows high efficacy against <i>Trichomonas vaginalis<\/i>. <i>Int. J. Antimicrob. Agents<\/i>, <b>45<\/b>, 434\u2013437 (2015).","DOI":"10.1016\/j.ijantimicag.2014.12.024"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Klepser ME, Wolfe EJ, Jones RN, Nightingale CH, Pfaller MA. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against <i>Candida albicans<\/i>. <i>Antimicrob. Agents Chemother.<\/i>, <b>41<\/b>, 1392\u20131395 (1997).","DOI":"10.1128\/AAC.41.6.1392"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Agarwal V, Lal P, Pruthi V. Prevention of <i>Candida albicans<\/i> biofilm by plant oils. <i>Mycopathologia<\/i>, <b>165<\/b>, 13\u201319 (2008).","DOI":"10.1007\/s11046-007-9077-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ramage G, Coco B, Sherry L, Bagg J, Lappin DF. <i>In vitro<\/i> <i>Candida albicans<\/i> biofilm induced proteinase activity and SAP8 expression correlates with <i>in vivo<\/i> denture stomatitis severity. <i>Mycopathologia<\/i>, <b>174<\/b>, 11\u201319 (2012).","DOI":"10.1007\/s11046-012-9522-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tobudic S, Kratzer C, Lassnigg A, Graninger W, Presterl E. <i>In vitro<\/i> activity of antifungal combinations against <i>Candida albicans<\/i> biofilms. <i>J. Antimicrob. Chemother.<\/i>, <b>65<\/b>, 271\u2013274 (2010).","DOI":"10.1093\/jac\/dkp429"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Dutton LC, Nobbs AH, Jepson K, Jepson MA, Vickerman MM, Aqeel Alawfi S, Munro CA, Lamont RJ, Jenkinson HF. <i>O<\/i>-Mannosylation in <i>Candida albicans<\/i> enables development of interkingdom biofilm communities. <i>MBio<\/i>, <b>5<\/b>, e00911\u2013e00914 (2014).","DOI":"10.1128\/mBio.00911-14"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Nett JE, Sanchez H, Cain MT, Ross KM, Andes DR. Interface of <i>Candida albicans<\/i> biofilm matrix-associated drug resistance and cell wall integrity regulation. <i>Eukaryot. Cell<\/i>, <b>10<\/b>, 1660\u20131669 (2011).","DOI":"10.1128\/EC.05126-11"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Cao Y, Dai B, Wang Y, Huang S, Xu Y, Cao Y, Gao P, Zhu Z, Jiang Y. <i>In vitro<\/i> activity of baicalein against <i>Candida albicans<\/i> biofilms. <i>Int. J. Antimicrob. Agents<\/i>, <b>32<\/b>, 73\u201377 (2008).","DOI":"10.1016\/j.ijantimicag.2008.01.026"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hwang IS, Lee J, Hwang JH, Kim KJ, Lee DG. Silver nanoparticles induce apoptotic cell death in <i>Candida albicans<\/i> through the increase of hydroxyl radicals. <i>FEBS J.<\/i>, <b>279<\/b>, 1327\u20131338 (2012).","DOI":"10.1111\/j.1742-4658.2012.08527.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mayer FL, Wilson D, Hube B. <i>Candida albicans<\/i> pathogenicity mechanisms. <i>Virulence<\/i>, <b>4<\/b>, 119\u2013128 (2013).","DOI":"10.4161\/viru.22913"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ramage G, Jose A, Coco B, Rajendran R, Rautemaa R, Murray C, Lappin DF, Bagg J. Commercial mouthwashes are more effective than azole antifungals against <i>Candida albicans<\/i> biofilms <i>in vitro<\/i>. <i>Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.<\/i>, <b>111<\/b>, 456\u2013460 (2011).","DOI":"10.1016\/j.tripleo.2010.10.043"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP. Cell density and cell aging as factors modulating antifungal resistance of <i>Candida albicans<\/i> biofilms. <i>Antimicrob. Agents Chemother.<\/i>, <b>52<\/b>, 3259\u20133266 (2008).","DOI":"10.1128\/AAC.00541-08"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Onivogui G, Diaby M, Chen X, Zhang H, Kargbo MR, Song Y. Antibacterial and antifungal activities of various solvent extracts from the leaves and stem bark of <i>Anisophyllea laurina<\/i> R. Br ex Sabine used as traditional medicine in Guinea. <i>J. Ethnopharmacol.<\/i>, <b>168<\/b>, 287\u2013290 (2015).","DOI":"10.1016\/j.jep.2015.03.055"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Wang W, Guo J, Zhang J, Liu T, Xin Z. New screw lactam and two new carbohydrate derivatives from the methanol extract of rice bran. <i>J. Agric. Food Chem.<\/i>, <b>62<\/b>, 10744\u201310751 (2014).","DOI":"10.1021\/jf5037273"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Lal P, Sharma D, Pruthi P, Pruthi V. Exopolysaccharide analysis of biofilm-forming <i>Candida albicans<\/i>. <i>J. Appl. Microbiol.<\/i>, <b>109<\/b>, 128\u2013136 (2010).","DOI":"10.1111\/j.1365-2672.2009.04634.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA, Hoyer LL. RT-PCR detection of <i>Candida albicans<\/i> ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. <i>Microbiology<\/i>, <b>150<\/b>, 267\u2013275 (2004).","DOI":"10.1099\/mic.0.26699-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Li Y, Chang W, Zhang M, Ying Z, Lou H. Natural product solasodine-3-<i>O<\/i>-\u03b2-D-glucopyranoside inhibits the virulence factors of <i>Candida albicans<\/i>. <i>FEMS Yeast Res.<\/i>, <b>15<\/b>, fov060 (2015).","DOI":"10.1093\/femsyr\/fov060"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Romeo O, Criseo G. First molecular method for discriminating between <i>Candida africana<\/i>, <i>Candida albicans<\/i>, and <i>Candida dubliniensis<\/i> by using hwp1 gene. <i>Diagn. Microbiol. Infect. Dis.<\/i>, <b>62<\/b>, 230\u2013233 (2008).","DOI":"10.1016\/j.diagmicrobio.2008.05.014"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lane S, Birse C, Zhou S, Matson R, Liu H. DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in <i>Candida albicans<\/i>. <i>J. Biol. Chem.<\/i>, <b>276<\/b>, 48988\u201348996 (2001).","DOI":"10.1074\/jbc.M104484200"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chang W, Li Y, Zhang L, Cheng A, Lou H. Retigeric acid B attenuates the virulence of <i>Candida albicans<\/i> <i>via<\/i> inhibiting adenylyl cyclase activity targeted by enhanced farnesol production. <i>PLoS ONE<\/i>, <b>7<\/b>, e41624 (2012).","DOI":"10.1371\/journal.pone.0041624"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Moore JE, Xu J, Millar BC, Crowe M, Elborn JS. Improved molecular detection of <i>Burkholderia cepacia<\/i> genomovar III and <i>Burkholderia multivorans<\/i> directly from sputum of patients with cystic fibrosis. <i>J. Microbiol. Methods<\/i>, <b>49<\/b>, 183\u2013191 (2002).","DOI":"10.1016\/S0167-7012(01)00367-0"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Finkel JS, Mitchell AP. Genetic control of <i>Candida albicans<\/i> biofilm development. <i>Nat. Rev. Microbiol.<\/i>, <b>9<\/b>, 109\u2013118 (2011).","DOI":"10.1038\/nrmicro2475"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Bujd\u00e1kov\u00e1 H, Kulkov\u00e1 N, \u010cern\u00e1kov\u00e1 L. Susceptibility to caspofungin and fluconazole and Als1\/Als3 gene expression in biofilm and dispersal cells of <i>Candida albicans<\/i>. <i>Arh. Hig. Rada Toksikol.<\/i>, <b>63<\/b>, 497\u2013503 (2012).","DOI":"10.2478\/10004-1254-63-2012-2236"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Monroy-P\u00e9rez E, S\u00e1inz-Espu\u00f1es T, Paniagua-Contreras G, Negrete-Abascal E, Rodr\u00edguez-Moctezuma JR, Vaca S. Frequency and expression of ALS and HWP1 genotypes in <i>Candida albicans<\/i> strains isolated from Mexican patients suffering from vaginal candidosis. <i>Mycoses<\/i>, <b>55<\/b>, e151\u2013e157 (2012).","DOI":"10.1111\/j.1439-0507.2012.02188.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yeater KM, Chandra J, Cheng G, Mukherjee PK, Zhao X, Rodriguez-Zas SL, Kwast KE, Ghannoum MA, Hoyer LL. Temporal analysis of <i>Candida albicans<\/i> gene expression during biofilm development. <i>Microbiology<\/i>, <b>153<\/b>, 2373\u20132385 (2007).","DOI":"10.1099\/mic.0.2007\/006163-0"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kuchar\u00edkov\u00e1 S, Tournu H, Lagrou K, Van Dijck P, Bujdakova H. Detailed comparison of <i>Candida albicans<\/i> and <i>Candida glabrata<\/i> biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. <i>J. Med. Microbiol.<\/i>, <b>60<\/b>, 1261\u20131269 (2011).","DOI":"10.1099\/jmm.0.032037-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of <i>Candida albicans<\/i> Hwp1. <i>Science<\/i>, <b>283<\/b>, 1535\u20131538 (1999).","DOI":"10.1126\/science.283.5407.1535"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Fanning S, Xu W, Solis N, Woolford CA, Filler SG, Mitchell AP. Divergent targets of <i>Candida albicans<\/i> biofilm regulator Bcr1 <i>in vitro<\/i> and <i>in vivo<\/i>. <i>Eukaryot. Cell<\/i>, <b>11<\/b>, 896\u2013904 (2012).","DOI":"10.1128\/EC.00103-12"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Nobile CJ, Andes DR, Nett JE, Smith FJ Jr, Yue F, Phan Q-T, Edwards JE Jr, Filler SG, Mitchell AP. Critical role of Bcr1-dependent adhesins in <i>C. albicans<\/i> biofilm formation <i>in vitro<\/i> and <i>in vivo<\/i>. <i>PLoS Pathog.<\/i>, <b>2<\/b>, e63 (2006).","DOI":"10.1371\/journal.ppat.0020063"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Bailey DA, Feldmann P, Bovey M, Gow N, Brown A. The <i>Candida albicans<\/i> HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. <i>J. Bacteriol.<\/i>, <b>178<\/b>, 5353\u20135360 (1996).","DOI":"10.1128\/jb.178.18.5353-5360.1996"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Braun BR, Johnson AD. TUP1, CPH1 and EFG1 make independent contributions to filamentation in <i>Candida albicans<\/i>. <i>Genetics<\/i>, <b>155<\/b>, 57\u201367 (2000).","DOI":"10.1093\/genetics\/155.1.57"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Dieterich C, Schandar M, Noll M, Johannes F-J, Brunner H, Graeve T, Rupp S. <i>In vitro<\/i> reconstructed human epithelia reveal contributions of <i>Candida albicans<\/i> EFG1 and CPH1 to adhesion and invasion. <i>Microbiology<\/i>, <b>148<\/b>, 497\u2013506 (2002).","DOI":"10.1099\/00221287-148-2-497"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/12\/39_b16-00380\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T22:14:50Z","timestamp":1657232090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/12\/39_b16-00380\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00380","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}